So-Young International (SY) has released an update.
So-Young International reported a net income increase to RMB20.3 million for Q3 2024, despite a slight decline in total revenue. The company’s strategic focus on medical product sales and expanding its clinic network has driven significant growth in non-GAAP net income. This positions So-Young as a strong player in the medical aesthetics market, poised for future expansion.
For further insights into SY stock, check out TipRanks’ Stock Analysis page.